Celia Reyes-Acuna
Corpus Christi, TXNPI 1598712143
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $591 and has fallen 62.4% since, to $222 in 2024.
Across 18 payments — averaging $73.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$299
- GSK$256
- Merck$188
- Travere Therapeutics, Inc.$120
- Rhythm Pharmaceuticals, Inc.$112
- Biogen$92
- plus $253 from 3 others
Across 506 payments — averaging $10,726 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$2.5M
- Merck$1.8M
- Novavax Inc$585K
- Eisai Inc.$278K
- Sanofi Pasteur Inc.$114K
- Pfizer$55K
- plus $79K from 2 others
What the payments were for
- Food & beverage$1,320100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 3 | $299 |
| GSK | 4 | $256 |
| Merck | 5 | $188 |
| Travere Therapeutics, Inc. | 1 | $120 |
| Rhythm Pharmaceuticals, Inc. | 1 | $112 |
| Biogen | 1 | $92 |
| Biofire Diagnostics, LLC | 1 | $90 |
| Novartis | 1 | $90 |
| Genentech, Inc. | 1 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEXSERO$218
- (815) Thiola$120
- VAXNEUVANCE$105
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.